TUDOR INVESTMENT CORP ET AL - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 242 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,396,088
+22.5%
51,242
+0.0%
0.01%0.0%
Q2 2023$1,139,578
+109791.8%
51,217
+7.0%
0.01%
-12.5%
Q1 2023$1,037
-99.9%
47,879
+39.0%
0.02%
-15.8%
Q3 2022$883,000
-32.2%
34,457
-55.5%
0.02%
-70.8%
Q2 2020$1,302,000
-36.7%
77,417
-55.3%
0.06%
-64.7%
Q1 2020$2,058,000
+6.7%
173,060
+8.5%
0.18%
+111.5%
Q4 2019$1,929,000
-22.2%
159,454
-9.1%
0.09%
+2.4%
Q3 2019$2,479,000
-6.3%
175,362
-26.1%
0.08%
+13.3%
Q2 2019$2,646,000
+4.6%
237,266
+10.1%
0.08%
-28.6%
Q1 2019$2,530,000
+16.6%
215,460
+32.7%
0.10%
+144.2%
Q4 2018$2,170,000
+483.3%
162,402
+512.8%
0.04%
+377.8%
Q3 2018$372,000
+118.8%
26,500
+155.7%
0.01%
+50.0%
Q1 2018$170,000
-74.6%
10,364
-70.2%
0.01%
-64.7%
Q3 2017$670,000
+337.9%
34,734
+47.4%
0.02%
+325.0%
Q3 2016$153,000
-1.3%
23,564
-17.2%
0.00%
+33.3%
Q2 2016$155,000
+14.8%
28,449
-1.2%
0.00%0.0%
Q1 2016$135,0000.0%28,799
+6.3%
0.00%
-25.0%
Q4 2015$135,000
+68.8%
27,099
+27.4%
0.00%
+33.3%
Q3 2015$80,00021,2790.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,911,376$155,644,0006.95%
Parallel Advisors, LLC 1,944,319$47,014,0001.86%
TANAKA CAPITAL MANAGEMENT INC 39,289$885,0001.79%
S&T BANK/PA 508,546$11,452,0001.73%
Bridge City Capital, LLC 83,967$1,891,0000.88%
Birchview Capital, LP 50,000$1,126,0000.81%
Quantedge Capital Pte Ltd 113,012$2,545,0000.75%
FAS Wealth Partners, Inc. 289,625$6,522,0000.61%
AJ WEALTH STRATEGIES, LLC 396,029$8,919,0000.44%
TRUSTCORE FINANCIAL SERVICES, LLC 208,806$4,702,0000.41%
View complete list of CORCEPT THERAPEUTICS INC shareholders